valsartan has been researched along with Vascular Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, X; Guo, J; Li, Y; Liu, X; Peng, L; Sun, T; Tang, X; Xu, Q; Yang, X; Yu, H; Zhou, J | 1 |
| Huo, Y; Lei, L; Mao, Y; Meng, L; Qi, Y; Su, J; Tang, C | 1 |
2 other study(ies) available for valsartan and Vascular Injuries
| Article | Year |
|---|---|
Valsartan Prevented Neointimal Hyperplasia and Inhibited SRSF1 Expression and the TLR4-iNOS-ERK-AT1 Receptor Pathway in the Balloon-injured Rat Aorta.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Male; Neointima; Nitric Oxide Synthase Type II; Phosphorylation; Rats, Wistar; Receptor, Angiotensin, Type 1; Serine-Arginine Splicing Factors; Signal Transduction; Toll-Like Receptor 4; Valsartan; Vascular System Injuries | 2021 |
Impaired regulator of G protein signaling 2 transcription facilitates vascular remodeling in injured rat aorta.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Male; Muscle, Smooth, Vascular; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tetrazoles; Valine; Valsartan; Vascular Remodeling; Vascular System Injuries | 2014 |